Solid tumors encompass a diverse range of cancers affecting specific organs and tissues. Breast and prostate cancers are highly prevalent, with ongoing advancements in targeted therapies and hormonal treatments improving patient outcomes. Lung cancer research focuses on personalized medicine, utilizing biomarkers to tailor treatments. Colorectal cancer studies emphasize the role of gut microbiota and immunotherapy in disease progression and treatment. Pancreatic cancer remains one of the most lethal forms, with efforts directed toward early detection and innovative therapies. Liver cancer research highlights the significance of antiviral treatments in hepatitis-associated cases. Ovarian cancer advancements include precision surgery and novel chemotherapy regimens. These research areas collectively aim to enhance survival rates and improve the quality of life for cancer patients.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States